| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | WO2002024746A1 Transfer factor from birds eggs |
| 03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024698A1 Xanthine phosphodiesterase v inhibitors |
| 03/28/2002 | WO2002024695A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | WO2002024652A1 Compounds and methods for diagnosing and treating amyloid-related conditions |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 03/28/2002 | WO2002024610A2 Method for producing an antineoplastic |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2002024217A1 Use of il-8 protein modulators in the treatment of viral infections |
| 03/28/2002 | WO2002024214A2 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 03/28/2002 | WO2002024212A1 Cholesterol in blood-lowering composition and its complex, and method for preparing them |
| 03/28/2002 | WO2002024204A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 03/28/2002 | WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | WO2002024185A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 03/28/2002 | WO2002024180A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 03/28/2002 | WO2002024179A2 Method for reducing toxicity of combined chemotherapies |
| 03/28/2002 | WO2002024177A2 Methods of identifying inhibitory compounds and uses thereof |
| 03/28/2002 | WO2002024169A1 Spray drying process and compositions of fenofibrate |
| 03/28/2002 | WO2002024154A2 Method for topical treatment of anthralin-responsive dermatological disorders |
| 03/28/2002 | WO2002024148A2 Method or treatment of tumors using transforming growth factor-alpha |
| 03/28/2002 | WO2002024144A2 Use of transcription factors for treating inflammation and other diseases |
| 03/28/2002 | WO2002011743A3 Treatment of prostate cancer |
| 03/28/2002 | WO2002002595A9 Amphipathic linear peptides and compositions containing same |
| 03/28/2002 | WO2002000266A3 A method of treating and preventing infectious diseases |
| 03/28/2002 | WO2001097751A3 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 03/28/2002 | WO2001094952A3 Methods and compositions for modulating oxidized ldl transport |
| 03/28/2002 | WO2001091785A3 Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 03/28/2002 | WO2001089479A3 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 03/28/2002 | WO2001087281A3 Method for enhancing cognitive function |
| 03/28/2002 | WO2001085781A3 Repair of nerve damage |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001085169A3 R-eliprodil for treating glaucoma |
| 03/28/2002 | WO2001085152A3 R-eliprodil for treating glaucoma |
| 03/28/2002 | WO2001080844A3 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 03/28/2002 | WO2001078706A3 Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism |
| 03/28/2002 | WO2001078653A3 Graft rejection inhibition with ccr2 inhibitors |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001077150A3 Serine-threonine kinase |
| 03/28/2002 | WO2001076575A3 The treatment of respiratory diseases |
| 03/28/2002 | WO2001076370A3 Anthelmintic combinations |
| 03/28/2002 | WO2001066144A3 Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity |
| 03/28/2002 | WO2001066124A3 Composition for the treatment of heart failure |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001064217A3 Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents |
| 03/28/2002 | WO2001064203A3 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q¿10? |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001056553A3 Pharmaceutically active aromatic guanylhydrazones |
| 03/28/2002 | WO2001055341A3 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| 03/28/2002 | WO2001052825A3 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001045686A3 Formulations of adenosine a1 agonists |
| 03/28/2002 | WO2001032216A3 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/28/2002 | WO2001022955A2 Novel combination of loteprednol and antihistamines |
| 03/28/2002 | WO2001019353A3 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/28/2002 | WO2001015677A3 Use of 5-ht1b/1d agonists to treat otic pain |
| 03/28/2002 | WO2001015674A3 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000056295A3 Oral combinations of hydroxocobalamin and folic acid |
| 03/28/2002 | WO2000048621A9 Methods and compositions for regulating protein-protein interactions |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | US20020037930 Both malignant and benign neoplasms |
| 03/28/2002 | US20020037928 For treatment of diabetes mellitus; for example sulfonamide derivatives of given formula and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists |
| 03/28/2002 | US20020037927 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/28/2002 | US20020037926 And gabapentin and/or pregabalin or their salts to prevent or ameliorate chronic pain or convulsions; synergistic |
| 03/28/2002 | US20020037924 Small molecule carbamate or urea hair growth compositions and uses |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037914 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 03/28/2002 | US20020037908 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating Alzheimer's disease or Creutzfelds-Jakob disease for example |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037887 Method for reducing intraocular pressure using indole derivatives |
| 03/28/2002 | US20020037880 Method of inhibiting hair growth |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037863 Novel anthelmintic combinations |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037843 Method and composition for modulating amyloidosis |
| 03/28/2002 | US20020037836 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/28/2002 | US20020037828 Pretreatment sexual intercourse |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037544 Detecting modulators of phosphorylation; obtain sample, incubate with modulator, screen sample for adjustment in phosphorylation activity |
| 03/28/2002 | US20020037543 Purging of cells using viruses |
| 03/28/2002 | US20020037538 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | US20020037328 Hexitol compositions and uses thereof |
| 03/28/2002 | US20020037297 For therapy and prophylaxis allergic rhinitis, vasomotoric rhinitis, conjunctivitis, cold, and flu |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |